YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Local Irritant Effects of Topical Oral Sprays on Oral Mucosa in Mice

dc.authorscopusid 8579314800
dc.authorscopusid 56208434400
dc.authorscopusid 55560130600
dc.authorscopusid 7005912992
dc.authorscopusid 6602084287
dc.authorwosid Ozbek, Hanefi/O-3472-2019
dc.contributor.author Yuca, K
dc.contributor.author Çankaya, H
dc.contributor.author Bayram, W
dc.contributor.author Özbek, H
dc.contributor.author Kiris, M
dc.date.accessioned 2025-05-10T17:29:07Z
dc.date.available 2025-05-10T17:29:07Z
dc.date.issued 2006
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp Yuzuncu Yil Univ, Fac Med, Dept Otorhinolaryngol, TR-65200 Van, Turkey; Yuzuncu Yil Univ, Fac Med, Dept Pathol, TR-65200 Van, Turkey; Yuzuncu Yil Univ, Fac Med, Dept Pharmacol, TR-65200 Van, Turkey en_US
dc.description.abstract Topical oral sprays are frequently used to prevent and manage oropharyngeal inflammation and lesions. This study investigated the histopathologic changes noted in the oral mucosa of mice after topical application of 3 widely prescribed antibacterial products. The 25 animals were divided into 5 groups and treated for 10 days with 2 sprays daily, as follows: group 1 - chlorhexidine gluconate 0.12% * benzydamine hydrochloride 0.15%; group 2 - benzydamine 0.27 mg/0.18 mL * 30 mL; group 3 - chlorhexidine 0.2%; group 4 - fusafungine 1%; and group 5 (cohort) - physiologic serum. On day 10 after drug administration, biopsy specimens were taken from the oropharyngeal mucosa of the tongue, the cheek mucosa, and the tongue base; these were examined under a light microscope and were classified as normal or pathologic. All topical oral sprays produced some degree of histopathologic change, such as hyperplasia, fibrosis, low-grade dysplasia, congestion, or edema. The local irritant effects of topical oral sprays should be considered when treatment is selected for patients with oropharyngeal disorder. en_US
dc.description.woscitationindex Science Citation Index Expanded
dc.identifier.doi 10.1007/BF02850351
dc.identifier.endpage 106 en_US
dc.identifier.issn 0741-238X
dc.identifier.issn 1865-8652
dc.identifier.issue 1 en_US
dc.identifier.pmid 16644611
dc.identifier.scopus 2-s2.0-33646123750
dc.identifier.scopusquality Q1
dc.identifier.startpage 98 en_US
dc.identifier.uri https://doi.org/10.1007/BF02850351
dc.identifier.uri https://hdl.handle.net/20.500.14720/12247
dc.identifier.volume 23 en_US
dc.identifier.wos WOS:000237118900011
dc.identifier.wosquality Q2
dc.language.iso en en_US
dc.publisher Springer en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Topical Oral Sprays en_US
dc.subject Oropharyngeal Mucosa en_US
dc.subject Swiss Albino Mice en_US
dc.title Local Irritant Effects of Topical Oral Sprays on Oral Mucosa in Mice en_US
dc.type Article en_US

Files